Sensus Healthcare Inc. is a publicly traded company involved in the medical technology sector, primarily focusing on non-invasive treatments for patients. The company's flagship offerings include mobile superficial radiation therapy (SRT) systems, notably the SRT-100. These devices are primarily used to treat non-melanoma skin cancers and keloids with precision while minimizing damage to surrounding healthy tissues. Sensus Healthcare's technology caters to dermatologists, oncologists, and healthcare facilities, providing an alternative to surgery for treating skin-related conditions. The company's role in the healthcare market is significant due to its emphasis on patient-friendly, non-surgical procedures that reduce recovery times and medical costs. Established in the early 2000s, Sensus Healthcare operates mainly in the United States but is expanding its reach internationally, driven by increasing awareness and demand for non-surgical medical solutions.